рдЖрдЧреЗрдЕрдЧрд▓реА рдЧрд╛рдЗрдб
FDA Clinical Decision Support Software Guidance
рд╕рдорд╛рдЬ
рдЙрджреНрдпреЛрдЧ рдЧрд╛рдЗрдб
Clinical decision support (CDS) is software, usually built into or connected to the electronic health record, that gives clinicians patient-specific alerts, reminders, order sets and risk predictions while they care for a patient.
рдЗрд╕ рдЧрд╛рдЗрдб рдХреЛ рд╕реБрдиреЗрдВрдПрдЖрдИ-рдиреИрд░реЗрдЯреЗрдб ┬╖ ~3 min
It matters because well-designed CDS catches drug interactions, dosing errors and missed diagnoses. Poorly designed CDS causes alert fatigue, where clinicians override most warnings, including the important ones.
CDS falls into two broad families. Knowledge-based CDS runs explicit rules written by clinicians and pharmacists, such as drug-drug interaction checks, allergy checks, dose ranges, preventive care reminders and order sets. Predictive CDS uses statistical or machine learning models trained on past patient data to estimate risk of events such as sepsis, deterioration, readmission or no-shows. Delivery can be interruptive (a pop-up that stops the workflow), passive (a flag, a banner or a default choice in an order), or routed to someone else, such as a pharmacist or a rapid response team. Informaticists often use the "five rights" framework: the right information, to the right person, in the right format, through the right channel, at the right time. Alerts that break these rules produce alert fatigue. Many studies of drug interaction alerts have found that clinicians override the large majority of them, often well above 90 percent in some settings, largely because so many alerts are clinically irrelevant. Once clinicians learn that most alerts are noise, they also dismiss the rare one that matters. Predictive models add another risk: they can perform worse in practice than their developers reported. In 2021 a University of Michigan team published an external validation of the Epic Sepsis Model in JAMA Internal Medicine. It found much weaker discrimination than advertised (an AUC of about 0.63). The model missed about two thirds of sepsis cases while generating alerts on many patients who did not have sepsis. On regulation, the 21st Century Cures Act of 2016 excluded some CDS from FDA device regulation, mainly tools whose basis a clinician can independently review, and the FDA issued final CDS guidance in 2022. ONC's HTI-1 rule, finalized in late 2023, requires certified EHRs to expose information about decision support interventions, including predictive ones. The common misconception is that more alerts mean safer care. Past a point, more alerts make care less safe.
When a physician orders an antibiotic for a patient on warfarin, the EHR shows an interruptive interaction alert suggesting closer INR monitoring. The physician must acknowledge it or give an override reason.
A renal dosing rule reads the patient's latest eGFR and suggests a lower dose of a renally cleared drug inside the order itself, without a pop-up.
A hospital's sepsis prediction model scores inpatients every few hours and sends a best practice advisory to the rapid response nurse when the score passes a threshold.
An emergency physician opens a community-acquired pneumonia order set that preselects guideline-recommended antibiotics and a severity score calculator.
Language models are starting to appear in CDS as chart summarizers and question-answering tools, not only as rule engines. That raises new questions about how to validate a tool whose output is free text. Transparency rules such as HTI-1 push vendors to document how predictive tools were trained and tested, which should make local evaluation easier. The lesson from sepsis models and interaction alerts is likely to hold for newer tools as well: local validation, measured alert burden and routing to the right person decide whether CDS helps. Health systems that retire low-value alerts may gain as much as those that add new ones.
рдореБрдлрд╝реНрдд рдиреНрдпреВрдЬрд╝рд▓реЗрдЯрд░
рд╣рд░ рдХрд╛рд░реНрдпрджрд┐рд╡рд╕ рдХреА рд╕реБрдмрд╣ рддреАрди рд╕рддреНрдпрд╛рдкрд┐рдд рдПрдЖрдИ рдХрд╣рд╛рдирд┐рдпрд╛рдБ, рд╕рд╛рджреЗ рдЕрдВрдЧреНрд░реЗрдЬреА рдореЗрдВ рд▓рд┐рдЦреА рдЧрдИрдВред рд╣рдореЗрд╢рд╛ рдХреЗ рд▓рд┐рдП рдореБрдлрд╝реНрдд, рдХреЛрдИ рд╡рд┐рдЬреНрдЮрд╛рдкрди рдирд╣реАрдВред
рдкреНрд░рддреНрдпреЗрдХ рд╕рдкреНрддрд╛рд╣ рдХреЗ рджрд┐рди рдПрдХ рдИрдореЗрд▓. рдПрдХ рдХреНрд▓рд┐рдХ рдореЗрдВ рд╕рджрд╕реНрдпрддрд╛ рд╕рдорд╛рдкреНрдд рдХрд░реЗрдВ. рд╣рдо рдЖрдкрдХрд╛ рдкрддрд╛ рдХрднреА рдирд╣реАрдВ рдмреЗрдЪрддреЗ рдпрд╛ рд╕рд╛рдЭрд╛ рдирд╣реАрдВ рдХрд░рддреЗред
рд╕реНрд╡рдпрдВ рдХреА рдЬрд╛рдВрдЪ рдХрд░реЛ
рдкреНрд░рддреНрдпреЗрдХ рдЙрддреНрддрд░ рдкрд░ рддреНрд╡рд░рд┐рдд рдкреНрд░рддрд┐рдХреНрд░рд┐рдпрд╛, рдФрд░ рдкрд╛рдареНрдпрдХреНрд░рдо рдкрд╛рд╕ рдХрд░рдиреЗ рдХреЗ рдмрд╛рдж рдПрдХ рд╕рддреНрдпрд╛рдкрди рдпреЛрдЧреНрдп рдЖрдИрдбреА рдХреЗ рд╕рд╛рде рдПрдХ рд╕рд╛рдЭрд╛ рдХрд░рдиреЗ рдпреЛрдЧреНрдп рдкреНрд░рдорд╛рдгрдкрддреНрд░ред
рдирд┐рдГрд╢реБрд▓реНрдХ рдПрдЖрдИ рд╢рд┐рдХреНрд╖рд╛ рдХрд╛ рд╕рдорд░реНрдерди рдХрд░реЗрдВред AI Understanding рдПрдХ 501(c)(3) рдЧреИрд░-рд▓рд╛рднрдХрд╛рд░реА рд╕рдВрд╕реНрдерд╛ рд╣реИ - рдХреЛрдИ рд╡рд┐рдЬреНрдЮрд╛рдкрди рдирд╣реАрдВ, рдХреЛрдИ рдкреЗрд╡реЙрд▓ рдирд╣реАрдВред рджрд╛рди рдХрд░реЗрдВ
Clinical decision support (CDS) is software, usually built into or connected to the electronic health record, that gives clinicians patient-specific alerts, reminders, order sets and risk predictions while they care for a patient. It matters because well-designed CDS catches drug interactions, dosing errors and missed diagnoses. Poorly designed CDS causes alert fatigue, where clinicians override most warnings, including the important ones.
рдЙрдЪреНрдЪ рдУрд╡рд░рд░рд╛рдЗрдб рджрд░реЗрдВ рдЕрдзрд┐рдХрддрд░ рдХрдо-рдореВрд▓реНрдп рд╡рд╛рд▓реЗ рдЕрд▓рд░реНрдЯ рд╕реЗ рдЖрддреА рд╣реИрдВред рдПрдХ рдмрд╛рд░ рдЬрдм рдЕрдзрд┐рдХрд╛рдВрд╢ рдЕрд▓рд░реНрдЯ рд╢реЛрд░ рд╣реЛрддреЗ рд╣реИрдВ, рддреЛ рдЪрд┐рдХрд┐рддреНрд╕рдХ рдЙрди рд▓реЛрдЧреЛрдВ рдХреЛ рднреА рдЦрд╛рд░рд┐рдЬ рдХрд░ рджреЗрддреЗ рд╣реИрдВ рдЬреЛ рдорд╛рдпрдиреЗ рд░рдЦрддреЗ рд╣реИрдВред
рдЕрдзреНрдпрдпрди рдореЗрдВ AUC рд▓рдЧрднрдЧ 0.63 рдкрд╛рдпрд╛ рдЧрдпрд╛ред рдореЙрдбрд▓ рдиреЗ рдЕрдзрд┐рдХрд╛рдВрд╢ рд╕реЗрдкреНрд╕рд┐рд╕ рдорд╛рдорд▓реЛрдВ рдХреЛ рдЫреЛрдбрд╝ рджрд┐рдпрд╛, рдЬрдмрдХрд┐ рдРрд╕реЗ рдХрдИ рд░реЛрдЧрд┐рдпреЛрдВ рдХреЛ рд╕рдЪреЗрдд рдХрд┐рдпрд╛, рдЬрд┐рдиреНрд╣реЗрдВ рд╕реЗрдкреНрд╕рд┐рд╕ рдирд╣реАрдВ рдерд╛ред
рдЪрд┐рдХрд┐рддреНрд╕рдХ рдХреЛ рд░реЛрдХреЗ рдмрд┐рдирд╛ рд╡рд░реНрдХрдлрд╝реНрд▓реЛ рдХреЗ рдЕрдВрджрд░ рдПрдХ рд╕реБрдЭрд╛рд╡ рджрд┐рдЦрд╛рдирд╛ рдирд┐рд╖реНрдХреНрд░рд┐рдп, рдЧреИрд░-рд╡реНрдпрд╡рдзрд╛рди рд╡рд┐рддрд░рдг рд╣реИред
рдИрдПрдЪрдЖрд░ рдСрд░реНрдбрд░-рд╕рд╛рдЗрди рдЬреИрд╕реЗ рд╣реБрдХ рдмрд┐рдВрджреБрдУрдВ рдкрд░ рд╕реЗрд╡рд╛ рдХреЛ рдХреЙрд▓ рдХрд░рддрд╛ рд╣реИ, рдФрд░ рд╕реЗрд╡рд╛ рдХрд╛рд░реНрдб рдХреЗ рд╕рд╛рде рдЙрддреНрддрд░ рджреЗрддреА рд╣реИ рдЬрд┐рд╕реЗ рдЪрд┐рдХрд┐рддреНрд╕рдХ рдкрдврд╝ рд╕рдХрддрд╛ рд╣реИ рдпрд╛ рдЙрд╕ рдкрд░ рдХрд╛рд░реНрдп рдХрд░ рд╕рдХрддрд╛ рд╣реИред
рд╕рд╛рдЗрд▓реЗрдВрдЯ рдореЛрдб рдмрд┐рдирд╛ рдХрд┐рд╕реА рдХреЛ рд╕рдЪреЗрдд рдХрд┐рдП рдорд░реАрдЬреЛрдВ рдХрд╛ рд╕реНрдХреЛрд░ рдХрд░рддрд╛ рд╣реИ, рдЗрд╕рд▓рд┐рдП рдЯреАрдо рдкрд╣рд▓реЗ рд╕реНрдерд╛рдиреАрдп рд╕рдЯреАрдХрддрд╛ рдФрд░ рдЕрд▓рд░реНрдЯ рд╡реЙрд▓реНрдпреВрдо рдХреА рдЬрд╛рдВрдЪ рдХрд░ рд╕рдХрддреА рд╣реИред
рд╕реАрдЦрддреЗ рд░рд╣реЛ
рдЗрд╕ рд╡рд┐рд╖рдп рдХреЗ рд▓рд┐рдП рдЕрдзрд┐рдХ рдорд╛рд░реНрдЧрджрд░реНрд╢рд┐рдХрд╛рдПрдБ рдЪреБрдиреА рдЧрдИрдВ
рдЖрдЧреЗрдЕрдЧрд▓реА рдЧрд╛рдЗрдб
FDA Clinical Decision Support Software Guidance
рд╕рдорд╛рдЬ